ACADIA PHARMACEUTICALS INC shareholders Q2 2023

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 237 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.

ACADIA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
PERSONAL CFO SOLUTIONS, LLC 12,781$306,1050.06%
Ergoteles LLC 52,188$1,249,9030.06%
Engineers Gate Manager LP 65,361$1,565,3960.06%
NJ State Employees Deferred Compensation Plan 17,000$407,1500.06%
Van Hulzen Asset Management, LLC 28,890$6920.06%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 514,574$12,324,0470.06%
GSA CAPITAL PARTNERS LLP 22,730$5440.05%
Y-Intercept (Hong Kong) Ltd 19,959$478,0180.05%
Rafferty Asset Management, LLC 336,029$8,047,8950.04%
Headlands Technologies LLC 5,562$133,2100.04%
Rockefeller Capital Management L.P. 404,289$9,682,7210.04%
PICTET ASSET MANAGEMENT SA 1,307,540$31,315,5830.04%
E Fund Management Co., Ltd. 18,068$4330.03%
State of Wyoming 4,625$110,7690.03%
J.W. COLE ADVISORS, INC. 17,885$428,3460.03%
Bayesian Capital Management, LP 11,837$283,4960.03%
Arete Wealth Advisors, LLC 12,650$3030.03%
QVT Financial LP 19,613$469,7310.03%
ALPS ADVISORS INC 119,536$2,862,8870.02%
C M BIDWELL & ASSOCIATES LTD 1,455$34,8470.02%
External links

This page lists ACADIA PHARMACEUTICALS INC's shareholders in Q2 2023. To view ACADIA PHARMACEUTICALS INC's shareholder history, click here.